Joost J C Verhoeff
Overview
Explore the profile of Joost J C Verhoeff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1212
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schuiveling M, Ter Maat L, Van Duin I, Verheijden R, Troenokarso M, Moeskops P, et al.
J Natl Cancer Inst
. 2025 Feb;
PMID: 39980388
Introduction: The association of body composition with checkpoint inhibitor outcomes in melanoma is a matter of ongoing debate. In this study, we aim to investigate body mass index (BMI) alongside...
2.
van Opijnen M, Nabuurs R, de Vos F, Ramsoedh M, Verhoeff J, Geurts M, et al.
Brain Spine
. 2025 Jan;
4():103923.
PMID: 39823067
Introduction: The optimal treatment for recurrent glioblastoma patients remains not well-defined in international guidelines. On top of that, the availability of national guidelines is uncharted. Research Question: This study aimed...
3.
Ter Maat L, De Mooij R, Van Duin I, Verhoeff J, Elias S, Leiner T, et al.
Sci Rep
. 2024 Dec;
14(1):31668.
PMID: 39738216
Immune checkpoint inhibitor (ICI) treatment has proven successful for advanced melanoma, but is associated with potentially severe toxicity and high costs. Accurate biomarkers for response are lacking. The present work...
4.
van der Pol L, Pomp J, Mohamed Hoesein F, Raaymakers B, Verhoeff J, Fast M
Phys Imaging Radiat Oncol
. 2024 Dec;
32:100686.
PMID: 39717185
Background/purpose: Radiation-induced cardiac toxicity in lung cancer patients has received increased attention since RTOG 0617. However, large cohort studies with accurate cardiac substructure (CS) contours are lacking, limiting our understanding...
5.
van der Pol L, Blanck O, Grehn M, Blazek T, Knybel L, Balgobind B, et al.
Radiother Oncol
. 2024 Nov;
202:110610.
PMID: 39489426
Background/purpose: High doses to healthy cardiac substructures (CS) in stereotactic arrhythmia radioablation (STAR) raise concerns regarding potential treatment-induced cardio-toxicity. However, CS contours are not routinely created, hindering the understanding of...
6.
Ehret F, El Baya L, Erridge S, Bussiere M, Verhoeff J, Niyazi M, et al.
Int J Radiat Oncol Biol Phys
. 2024 Oct;
121(3):599-612.
PMID: 39476990
Radiation therapy, including conventionally fractionated external beam radiation therapy, stereotactic radiosurgery, and fractionated stereotactic radiation therapy, is a cornerstone in the interdisciplinary management of meningiomas. Recent advances in radiation oncology...
7.
Pichler J, Traub-Weidinger T, Spiegl K, Imamovic L, Braat A, Snijders T, et al.
Neurooncol Adv
. 2024 Aug;
6(1):vdae130.
PMID: 39211520
Background: Glioblastoma (GBM), the most common malignant brain tumor, is associated with devastating outcomes. IPAX-1 was a multicenter, open-label, single-arm phase I study to evaluate carrier-added 4--[I]iodo-phenylalanine ([I]IPA) plus external...
8.
Miszczyk M, Hoeksema W, Kuna K, Blamek S, Cuculich P, Grehn M, et al.
Heart Rhythm
. 2024 Jul;
22(1):80-89.
PMID: 39032525
Stereotactic arrhythmia radioablation (STAR) is a noninvasive treatment of refractory ventricular tachycardia (VT). In this study, we aimed to systematically review prospective trials on STAR and pool harmonized outcome measures...
9.
van Grinsven E, Cialdella F, Gmelich Meijling Y, Verhoeff J, Philippens M, van Zandvoort M
Neurooncol Pract
. 2024 Jul;
11(4):441-451.
PMID: 39006520
Background: The increasing incidence of brain metastases (BMs) and improved survival rates underscore the necessity to investigate the effects of treatments on individuals. The aim of this study was to...
10.
Van Amsterdam W, de Jong P, Verhoeff J, Leiner T, Ranganath R
BMC Med Inform Decis Mak
. 2024 Apr;
24(1):111.
PMID: 38664664
In cancer research there is much interest in building and validating outcome prediction models to support treatment decisions. However, because most outcome prediction models are developed and validated without regard...